Skip to main content
MLAB logo

Mesa Laboratories, Inc.

MLABNASDAQTechnologyScientific & Technical Instruments

$128.66Today:- (-)1Y +64.08%

As of Oct 23, 2026 close

Market cap
$740.70M
P/E (TTM)
154.31
Forward P/E
-
Dividend yield
0.50%
52-week range
$69.51$144.35
Volume (live)
-
Avg. volume (3M)
108.97K

Mesa Laboratories (MLAB) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2026), Mesa Laboratories reported total assets of $427.75M and total liabilities of $241.50M. Shareholders' equity was $186.25M, up 16.5% from $159.83M a year earlier. Total debt stood at $151.48M against $26.93M in cash and short-term investments, a net debt position of $124.55M. That puts debt-to-equity at 0.81, compared with 1.11 a year earlier.

Mesa Laboratories Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Mesa Laboratories, Inc. (MLAB) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Current Assets
Cash and Cash Equivalents26.9327.3228.2132.9149.35263.8781.3810.195.475.82
Short-Term Investments0.001.750.000.000.000.000.000.000.000.00
Cash & Short-Term Investments26.9329.0728.2132.9149.35263.8781.3810.195.475.82
Accounts Receivable44.1041.9739.0642.5541.2223.7921.1312.5214.3014.32
Inventory26.3725.3732.6834.6424.6111.1814.236.779.2313.87
Other Current Assets3.628.039.414.059.144.926.054.152.991.77
Total Current Assets106.27102.69109.35118.98124.32303.75122.7933.6231.9935.79
Non-Current Assets
Property, Plant & Equipment (Net)30.6132.3341.4428.1528.6222.0022.0722.2323.5926.00
Long-Term Investments0.000.000.000.000.000.00-272.87-0.25-108.52-113.50
Goodwill186.86181.76180.10286.44291.17160.84141.5466.3865.5472.16
Intangible Assets83.3596.88113.75216.82250.12111.74119.8733.2242.8537.79
Other Non-Current Assets19.1619.700.8710.3711.832.53275.350.25108.52109.95
Total Non-Current Assets321.48330.66337.44542.86583.05297.73297.41123.14132.11135.95
Total Assets427.75433.35446.80661.83707.37601.48420.21156.77164.10171.73
Current Liabilities
Accounts Payable4.935.756.046.137.904.473.412.902.382.17
Short-Term Debt5.63101.052.992.872.771.021.102.131.631.13
Current Portion of Long-Term Debt5.63101.05--------
Accrued Liabilities2.2342.462.702.302.2019.33----
Deferred Revenue14.7214.7115.4815.6914.589.296.813.973.924.12
Other Current Liabilities32.949.3218.199.7514.859.368.6712.128.368.64
Total Current Liabilities61.90163.9644.3143.3648.0632.5826.0123.6617.2916.57
Non-Current Liabilities
Long-Term Debt145.8676.90228.31183.27218.37145.68140.2820.6144.6453.68
Deferred Tax Liabilities20.0920.1819.7834.0339.2216.2832.551.082.623.55
Other Non-Current Liabilities13.6632.659.007.697.920.721.360.110.190.12
Total Non-Current Liabilities179.60109.56257.09224.99265.51162.67174.1921.8047.4557.35
Total Liabilities241.50273.52301.40268.35313.57195.25200.1945.4664.7473.91
Stockholders' Equity
Common Stock375.35358.54343.64332.08313.46317.65158.0239.8230.5225.93
Retained Earnings-185.75-188.94-183.4974.2076.6872.4671.9373.3068.2873.66
Accumulated Other Comprehensive Income-3.36-9.78-14.76-12.803.6716.12-9.94-1.820.56-1.76
Shares Outstanding5.525.465.395.375.27-----
Total Stockholders' Equity186.25159.83145.39393.48393.80406.23220.01111.3199.3697.82
Total Liabilities & Equity427.75433.35446.80661.83707.37601.48420.21156.77164.10171.73

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Mesa Laboratories Balance Sheet

How much debt does Mesa Laboratories have?

Mesa Laboratories had total debt of $151.48M as of Mar 31, 2026, against $26.93M in cash and short-term investments. Its debt-to-equity ratio was 0.81. Total debt was $177.95M a year earlier.

What are Mesa Laboratories's total assets?

Mesa Laboratories reported total assets of $427.75M as of Mar 31, 2026, down 1.3% from $433.35M a year earlier. Total liabilities were $241.50M.

What is Mesa Laboratories's shareholders' equity?

Mesa Laboratories's shareholders' equity was $186.25M as of Mar 31, 2026, or about $33.71 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition